Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "69d8e821f75e521c210f0942",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Nilotinib 150mg",
"description": "NILOTHERAPY 150 is a prescription medication containing Nilotinib 150 mg, a targeted therapy primarily used in the treatment of certain types of blood cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins responsible for cancer cell growth. This medication is widely prescribed for patients diagnosed with Chronic Myeloid Leukemia (CML), especially those who are resistant or intolerant to other treatments.\n\nNILOTHERAPY 150 is designed to provide effective disease control while improving long-term outcomes and quality of life for patients.\n\nWhat is Nilotinib 150 mg?\n\nNilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, an abnormal protein produced in patients with Chronic Myeloid Leukemia. By inhibiting this protein, NILOTHERAPY 150 helps slow down or stop the uncontrolled growth of cancer cells.\n\nUnlike traditional chemotherapy, Nilotinib is a targeted therapy, meaning it focuses on cancer cells with minimal damage to healthy cells, making it a more precise and often better-tolerated treatment option.\n\nUses of NILOTHERAPY 150\n\nNILOTHERAPY 150 is primarily prescribed for:\n\n1. Chronic Myeloid Leukemia (CML)\nUsed in adults and children diagnosed with Philadelphia chromosome-positive CML.\nEffective in both newly diagnosed patients and those who cannot tolerate other treatments like Imatinib.\n2. Resistant or Intolerant CML Cases\nHelps patients who have not responded adequately to first-line therapies.\nOffers an alternative with improved efficacy in certain resistant mutations.\n3. Long-Term Disease Management\nHelps maintain remission and prevent disease progression to advanced stages such as accelerated or blast phase CML.\nKey Benefits of NILOTHERAPY 150\n1. Targeted Cancer Therapy\n\nNILOTHERAPY 150 directly targets cancer-causing proteins, minimizing damage to healthy cells and reducing many of the harsh side effects associated with chemotherapy.\n\n2. High Effectiveness\n\nClinical studies have shown that Nilotinib can achieve faster and deeper molecular responses compared to older treatments.\n\n3. Improved Survival Rates\n\nPatients using Nilotinib often experience better long-term survival outcomes when taken as prescribed.\n\n4. Oral Administration\n\nUnlike intravenous cancer treatments, NILOTHERAPY 150 is taken orally, making it convenient and easier to incorporate into daily life.\n\n5. Reduced Disease Progression\n\nHelps prevent the progression of CML into more aggressive stages, offering better disease control.\n\n6. Suitable for Resistant Cases\n\nEffective for patients who do not respond well to first-generation TKIs, providing a second chance at disease management.\n\nHow NILOTHERAPY 150 Works\n\nNilotinib works by blocking the activity of the BCR-ABL tyrosine kinase enzyme. This enzyme sends signals that tell cancer cells to grow and divide uncontrollably. By inhibiting this signal, NILOTHERAPY 150:\n\nStops cancer cell multiplication\nInduces cancer cell death\nHelps restore normal blood cell production\nDosage and Administration\nTypically taken twice daily on an empty stomach (at least 2 hours after a meal and 1 hour before the next meal).\nSwallow capsules whole with water.\nAlways follow your doctor’s prescribed dosage and schedule.\n\n⚠️ Do not adjust the dose without medical advice.\n\nPossible Side Effects of NILOTHERAPY 150\n\nLike all medications, NILOTHERAPY 150 may cause side effects. While not everyone experiences them, it’s important to be aware:\n\nCommon Side Effects\nHeadache\nNausea\nFatigue\nSkin rash\nConstipation or diarrhea\nSerious Side Effects\nHeart rhythm problems (QT prolongation)\nLiver function abnormalities\nPancreatitis\nLow blood cell counts\nIncreased blood sugar levels\nWhen to Seek Medical Help\n\nContact your doctor immediately if you experience:\n\nChest pain or irregular heartbeat\nSevere abdominal pain\nUnusual bleeding or bruising\nYellowing of skin or eyes\nPrecautions and Warnings\nInform your doctor if you have a history of heart disease, liver problems, or electrolyte imbalances.\nAvoid grapefruit and grapefruit juice as they may interfere with the drug’s effectiveness.\nRegular blood tests and monitoring are essential during treatment.\nNot recommended during pregnancy or breastfeeding unless advised by a healthcare professional.\nDrug Interactions\n\nNILOTHERAPY 150 may interact with other medications, including:\n\nAntifungal drugs\nAntibiotics\nHeart medications\nCertain antidepressants\n\nAlways inform your healthcare provider about all medicines and supplements you are taking.\n\nStorage Instructions\nStore in a cool, dry place below 25°C\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nNILOTHERAPY 150 (Nilotinib 150 mg) is a highly effective, targeted treatment for Chronic Myeloid Leukemia, offering patients a modern alternative to traditional chemotherapy. Its ability to specifically inhibit cancer-causing proteins makes it a powerful tool in controlling disease progression and improving long-term survival.",
"price": 3270.0,
"discountamount": 981.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2375,
"imageuri": "https://productimages.withfloats.com/actual/69d8e8255352fce06529f51e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69d8e8255352fce06529f51e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-04-10T12:08:01.629Z",
"updatedon": "2026-04-14T12:51:27.608Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/nilotinib-150mg/2375",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "NILOTHERAPY 150",
"category": "Oncology",
"tags": [
"nilotinib 150mg",
"nilotinib 150mg capsule",
"nilotinib side effects",
"nilotinib 150 mg price",
"nilotinib 150 mg",
"nilotinib 150 mg price",
"nilotinib 150mg availability in india",
"buy nilotinib 150mg online india prescription",
"nilotinib 150mg side effects long term use"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "69d8d9f47c7c4d696c414270",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Nilotinib 200mg",
"description": "NILOTHERAPY 200 is a targeted anti-cancer medication containing Nilotinib 200 mg, primarily used in the treatment of chronic myeloid leukemia (CML). It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking the abnormal proteins responsible for cancer cell growth.\n\nDeveloped to provide more precise and effective cancer treatment, NILOTHERAPY 200 offers improved outcomes compared to traditional therapies. It is commonly prescribed for patients who are newly diagnosed with CML or those who have not responded well to other treatments.\n\nWhat is Nilotinib and How Does It Work?\n\nNilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, a key driver of leukemia cell growth.\n\nMechanism of Action\nBlocks abnormal signals that promote cancer cell multiplication\nStops the growth and spread of leukemia cells\nHelps restore normal blood cell production\n\nUnlike chemotherapy, which affects both healthy and cancerous cells, Nilotinib works in a targeted manner, reducing damage to normal cells and improving treatment tolerability.\n\nUses of NILOTHERAPY 200\n1. Treatment of Chronic Myeloid Leukemia (CML)\n\nNILOTHERAPY 200 is widely used for:\n\nNewly diagnosed Philadelphia chromosome-positive CML\nChronic phase and accelerated phase CML\nPatients resistant or intolerant to prior therapies\n2. Long-Term Disease Control\n\nIt helps maintain remission and prevents disease progression when taken regularly as prescribed.\n\n3. Alternative to First-Line Therapies\n\nFor patients who do not respond well to other medications, NILOTHERAPY 200 serves as an effective alternative.\n\nKey Benefits of NILOTHERAPY 200\n1. Targeted Cancer Therapy\n\nNILOTHERAPY 200 specifically attacks cancer cells without extensively harming healthy cells, making it more precise than conventional chemotherapy.\n\n2. High Effectiveness in CML Management\n\nClinical studies have shown that Nilotinib provides:\n\nFaster molecular response\nImproved long-term survival rates\nReduced risk of disease progression\n3. Oral Convenience\n\nThe capsule form allows patients to take the medication at home, avoiding frequent hospital visits.\n\n4. Improved Quality of Life\n\nPatients often experience fewer severe side effects compared to traditional treatments, enabling better daily functioning.\n\n5. Suitable for Resistant Cases\n\nEffective in patients who have developed resistance to earlier therapies like imatinib.\n\nDosage and Administration\nTypically taken twice daily, approximately 12 hours apart\nMust be taken on an empty stomach (avoid food 2 hours before and 1 hour after)\nSwallow capsules whole with water\nFollow your doctor’s exact dosage instructions\nImportant Tip\n\nDo not skip doses or stop treatment without medical advice, as this may affect treatment outcomes.\n\nPossible Side Effects of NILOTHERAPY 200\n\nLike all medications, NILOTHERAPY 200 may cause side effects. While many are manageable, some require immediate attention.\n\nCommon Side Effects\nHeadache\nNausea\nFatigue\nConstipation or diarrhea\nMuscle or joint pain\nSerious Side Effects\nHeart rhythm problems (QT prolongation)\nLiver function abnormalities\nPancreatitis\nLow blood cell counts\nSudden weight gain or swelling\nWhen to Seek Medical Help\n\nContact your doctor immediately if you experience:\n\nIrregular heartbeat\nSevere abdominal pain\nYellowing of skin or eyes\nUnusual bleeding or bruising\nPrecautions and Warnings\n\nBefore starting NILOTHERAPY 200, consider the following:\n\nInform your doctor if you have heart disease, liver problems, or electrolyte imbalance\nRegular ECG monitoring may be required\nAvoid grapefruit and grapefruit juice during treatment\nNot recommended during pregnancy unless prescribed\nUse effective contraception during treatment\nDrug Interactions\n\nNilotinib may interact with:\n\nAntifungal medications\nAntibiotics\nHeart rhythm drugs\nAntacids\n\nAlways inform your healthcare provider about all medicines and supplements you are taking.\n\nStorage Instructions\nStore below 30°C in a dry place\nKeep away from moisture and direct sunlight\nKeep out of reach of children\nWhy Choose NILOTHERAPY 200?\n\nNilotherapy 200 stands out due to the following:\n\nAdvanced targeted therapy mechanism\nProven success in treating CML\nConvenient oral dosage\nEffective in resistant and intolerant cases\nTrusted pharmaceutical quality\nConclusion\n\nNILOTHERAPY 200 (Nilotinib 200 mg Capsules) is a powerful and reliable treatment option for patients with chronic myeloid leukemia. Its targeted mechanism, high effectiveness, and convenient oral administration make it a preferred choice among healthcare professionals.",
"price": 3570.0,
"discountamount": 1071.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2374,
"imageuri": "https://productimages.withfloats.com/actual/69d8d9fb0f2d50aed157389c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69d8d9fb0f2d50aed157389c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-04-10T11:07:32.379Z",
"updatedon": "2026-05-26T06:50:48.256Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//nilotinib-200mg/2374",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "NILOTHERAPY 200",
"category": "Oncology",
"tags": [
"nilotinib 200mg",
"nilotinib 200mg price",
"tab nilotinib 200mg",
"nilotinib 200mg price in india",
"nilotinib 200mg in hindi",
"nilotinib 200mg tab",
"nilotinib 200mg side effects",
"nilotinib 200mg brands in india",
"nilotinib 200mg uses",
"nilotinib 200mg price online",
"nilotinib 200mg generic vs branded price comparison0",
"is nilotinib 200mg available without prescription India",
"nilotinib 200mg lead time suppliers India",
"nilotinib 200mg vs imatinib price India",
"nilotinib 200mg exporters from India",
"nilotinib 200mg global suppliers GMP WHO certified",
"nilotinib 200mg hospital procurement price India",
"Buy Nilotinib 200mg Capsules Online",
"Nilotinib 200mg Anti Cancer Medicine",
"Nilotinib 200mg Prescription Medicine",
"Nilotinib 200mg Product Image",
"Best Leukemia Treatment Medicine Nilotinib",
"Nilotinib Capsules for Blood Cancer Treatment",
"Nilotinib 200mg Oncology Medicine",
"Targeted Cancer Therapy Capsules",
"Nilotinib 200mg Chemotherapy Support Medicine"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6943af86161ad9de85f42b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "imatinib 400mg",
"description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.",
"price": 1827.0,
"discountamount": 540.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2249,
"imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-18T07:38:46.766Z",
"updatedon": "2026-04-15T10:27:12.329Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//imatinib-400mg/2249",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "IMATIFLOW 400",
"category": "NEPHROLOGYRANGE",
"tags": [
"Imatinib IP 400mg",
"offering robust control over CML.",
"related cancers with a balance of efficacy and manageability.",
"innovative treatment maximizes hope and health in the fight against cancer.",
"cancer therapy.",
"fuel cancer cell growth.",
"chemotherapy.",
"imatinib 400mg.",
"imatinib 400mg tablet.",
"tab. imatinib 400mg.",
"imatinib 400mg price.",
"imatinib 400mg tab",
"imatinib 400mg side effects.",
"imatinib 400 mg tablet",
"imatinib 400 mg medicine",
"imatinib tablets 400 mg uses",
"imatinib 400 mg dosage",
"imatinib 400 mg price in india",
"imatinib 400 mg brand name"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662e95edb100e1fdc2dd5d6",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Imatinib IP 400mg",
"description": "IMATIFLOW 400 \nImatinib IP 400mg\n Cancer treatment has advanced significantly over the years, and targeted therapies have transformed outcomes for many patients. One such breakthrough medicine is Imatinib IP 400mg, marketed as IMATIFLOW 400. This medication is widely used in the treatment of certain types of cancers and blood disorders by targeting the underlying disease process at the molecular level.\n\nIMATIFLOW 400 is a trusted formulation of Imatinib that offers effective disease control while improving quality of life when used as prescribed under medical supervision.\n\nWhat Is Imatinib IP 400mg?\n\nImatinib IP 400mg belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs). Unlike traditional chemotherapy that attacks rapidly dividing cells, Imatinib works by specifically blocking abnormal proteins responsible for cancer cell growth.\n\nIMATIFLOW 400 is primarily prescribed for:\n\nChronic Myeloid Leukemia (CML)\n\nGastrointestinal Stromal Tumors (GIST)\n\nCertain rare blood and bone marrow disorders\n\nBy acting at the root cause of disease, Imatinib IP 400mg has become a cornerstone of modern targeted cancer therapy.\n\nHow IMATIFLOW 400 Works\n\nIMATIFLOW 400 works by inhibiting abnormal tyrosine kinase enzymes that signal cancer cells to grow and multiply uncontrollably.\n\nMechanism of Action:\n\nCancer cells produce abnormal proteins due to genetic mutations\n\nThese proteins send continuous growth signals\n\nImatinib blocks these signals\n\nCancer cell growth slows down or stops\n\nDiseased cells gradually die while healthy cells are largely spared\n\nThis targeted approach makes IMATIFLOW 400 more precise and often better tolerated compared to conventional chemotherapy.\n\nUses of Imatinib IP 400mg (IMATIFLOW 400)\n1. Chronic Myeloid Leukemia (CML)\n\nIMATIFLOW 400 is widely used as a first-line treatment for patients with Philadelphia chromosome-positive CML. It helps control disease progression and allows many patients to live longer, more stable lives.\n\n2. Gastrointestinal Stromal Tumors (GIST)\n\nIn patients with inoperable or metastatic GIST, Imatinib IP 400mg helps shrink tumors and prevent further growth.\n\n3. Acute Lymphoblastic Leukemia (ALL)\n\nIn certain cases of Philadelphia chromosome-positive ALL, IMATIFLOW 400 is used as part of combination therapy.\n\n4. Other Rare Conditions\n\nIMATIFLOW 400 may also be prescribed for:\n\nMyelodysplastic syndromes\n\nHypereosinophilic syndrome\n\nCertain dermatological and hematological disorders\n\nKey Benefits of IMATIFLOW 400\nTargeted Cancer Therapy\n\nIMATIFLOW 400 targets cancer cells at a molecular level, reducing unnecessary damage to healthy cells.\n\nImproved Survival Rates\n\nLong-term studies show that Imatinib significantly improves survival and disease control in CML and GIST patients.\n\nOral Administration\n\nUnlike injectable chemotherapy, IMATIFLOW 400 is taken orally, making treatment more convenient.\n\nBetter Quality of Life\n\nPatients often experience fewer severe side effects compared to traditional cancer therapies.\n\nLong-Term Disease Management\n\nMany patients remain on Imatinib therapy for years with stable disease control.\n\nAdvantages of IMATIFLOW 400 Over Conventional Chemotherapy\n\nSpecific action on cancer-causing proteins\n\nLower toxicity profile\n\nReduced hospital visits\n\nImproved patient compliance\n\nSuitable for long-term treatment\n\nThese advantages make IMATIFLOW 400 a preferred choice in targeted oncology care.\n\nDosage and Administration\n\nThe usual dose of Imatinib IP 400mg is one tablet once daily\n\nShould be taken with food and a full glass of water\n\nDosage may vary depending on disease type, stage, and patient response\n\nAlways follow the oncologist’s instructions strictly\n\nDo not stop or adjust the dose without medical advice, as this may affect treatment outcomes.\n\nSide Effects of Imatinib IP 400mg\n\nLike all medicines, IMATIFLOW 400 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nNausea and vomiting\n\nDiarrhea\n\nMuscle cramps\n\nFatigue\n\nHeadache\n\nSwelling around eyes or ankles\n\nMild skin rash\n\nThese side effects are usually manageable and improve as the body adjusts to the medicine.\n\nSerious Side Effects\n\nAlthough uncommon, some patients may experience serious side effects, including:\n\nSevere fluid retention\n\nLiver function abnormalities\n\nLow blood cell counts\n\nSevere skin reactions\n\nHeart-related complications (rare)\n\nImmediate medical attention is required if severe symptoms occur.\n\nPrecautions and Warnings\n\nRegular blood tests are required during treatment\n\nLiver function monitoring is important\n\nInform the doctor about all other medicines being taken\n\nUse with caution in patients with heart or liver disease\n\nNot recommended during pregnancy unless clearly advised\n\nBreastfeeding should be avoided during treatment\n\nDrug Interactions\n\nIMATIFLOW 400 may interact with:\n\nCertain antibiotics\n\nAntifungal medicines\n\nBlood thinners\n\nHerbal supplements like St. John’s Wort\n\nAlways inform your doctor about any medication or supplement you are using.\n\nWho Should Take IMATIFLOW 400?\n\nPatients diagnosed with CML\n\nPatients with GIST\n\nIndividuals prescribed targeted therapy by an oncologist\n\nPatients requiring long-term cancer management\n\nStorage Instructions\n\nStore at room temperature\n\nKeep away from moisture and heat\n\nKeep out of reach of children\n\nDo not use after the expiry date\n\nFrequently Asked Questions\nIs IMATIFLOW 400 chemotherapy?\n\nNo, it is a targeted therapy, not traditional chemotherapy.\n\nHow long should Imatinib IP 400mg be taken?\n\nTreatment duration depends on disease response and medical advice. Some patients take it long-term.\n\nCan IMATIFLOW 400 cure cancer?\n\nIt helps control and manage cancer effectively, and in many cases keeps the disease in remission.\n\nIs IMATIFLOW 400 safe for long-term use?\n\nYes, when monitored regularly under medical supervision.\n\nConclusion\n\nIMATIFLOW 400 (Imatinib IP 400mg) represents a major advancement in cancer treatment through its targeted mechanism of action. By directly blocking the proteins responsible for cancer growth, it offers effective disease control with improved tolerability. When taken correctly and under medical guidance, IMATIFLOW 400 can significantly enhance survival, stability, and quality of life for patients battling chronic and complex cancers.",
"price": 1827.0,
"discountamount": 549.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"CML",
"Call",
"GIST",
"Email",
"400mg",
"types",
"cancers",
"therapy",
"WhatsApp",
"IMATIFLOW",
"medication",
"information",
"Imatinib IP",
"progression",
"sterispharma",
"sterisonline",
"proliferation",
"patient outcomes",
"cancer cell growth",
"healthcare professional",
"chronic myeloid leukemia",
"specific tyrosine kinases",
"gastrointestinal stromal tumors"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1532,
"imageuri": "https://productimages.withfloats.com/actual/667d2405422dd0be2672303b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d2405422dd0be2672303b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T11:05:02.332Z",
"updatedon": "2026-03-16T11:55:37.907Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//imatinib-ip-400mg/1532",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "IMATIFLOW 400 ",
"category": "Oncology",
"tags": [
"imatinib 400 mg uses",
"side effects of imatinib 400 mg",
"imatinib 400 mg uses in hindi",
"imatinib 400 mg price in india",
"imatinib ip 400mg tablet",
"imatinib ip 400 mg uses",
"imatinib 400mg tablet ip",
"imatinib ip 400mg price in india",
"imatinib 400mg dosage guide",
"imatinib ip 400mg side effects",
"imatinib 400mg tablet composition",
"imatinib ip 400mg for leukemia",
"imatinib 400mg for cml treatment",
"imatinib ip 400mg medicine",
"imatinib 400mg tablet how to use",
"imatinib ip 400mg benefits",
"imatinib 400mg oral chemotherapy tablet",
"imatinib ip 400mg indications",
"imatinib 400mg tablet working mechanism",
"buy imatinib ip 400mg tablet",
"imatinib ip 400mg manufacturer india",
"imatinib 400mg tablet supplier",
"imatinib ip 400mg pharmaceutical company",
"what is imatinib ip 400mg",
"imatinib 400mg tablet for cancer",
"imatinib ip 400mg mechanism of action",
"imatinib 400mg tablet side effects in patients",
"imatinib ip 400mg treatment duration"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6662e74687f0960e14a2d95a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Gefitinib 250mg",
"description": "\n\nGEFISTERIS 250 is a premium pharmaceutical formulation containing Gefitinib 250mg, a breakthrough targeted therapy medication manufactured by Steris Healthcare. This innovative oral medication represents a significant advancement in the treatment of non-small cell lung cancer (NSCLC), offering patients a precise, scientifically-designed approach to combating one of the world's most challenging malignancies. GEFISTERIS 250 is specifically engineered to target the underlying molecular mechanisms that drive certain types of lung cancer, providing hope and extended survival for patients who carry specific genetic mutations.\nAs a tyrosine kinase inhibitor, GEFISTERIS 250 works at the cellular level to interrupt the signals that tell cancer cells to grow and divide. This targeted approach differs fundamentally from traditional chemotherapy, which affects both healthy and cancerous cells. By focusing specifically on cancer cells with epidermal growth factor receptor (EGFR) mutations, GEFISTERIS 250 offers a more refined treatment strategy with potentially fewer systemic side effects and improved quality of life during treatment.\nUnderstanding Gefitinib 250mg: The Science Behind GEFISTERIS 250\nGefitinib 250mg, the active pharmaceutical ingredient in GEFISTERIS 250, belongs to a revolutionary class of medications known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The development of this medication marked a paradigm shift in oncology, moving from one-size-fits-all chemotherapy approaches to personalized, mutation-specific treatments.\nThe EGFR protein is found on the surface of cells and plays a crucial role in cell growth and division. In normal cells, EGFR activation is carefully regulated. However, in certain lung cancers, mutations in the EGFR gene cause the receptor to remain constantly active, sending continuous signals for the cell to grow, divide, and survive—leading to uncontrolled cancer growth. GEFISTERIS 250 works by blocking the tyrosine kinase activity of the mutated EGFR protein, effectively turning off the growth signal and causing cancer cells to stop proliferating and eventually die.\nThis precision targeting is what makes GEFISTERIS 250 particularly effective for patients whose tumors harbor activating EGFR mutations, particularly the common exon 19 deletions or exon 21 L858R substitution mutations. Before initiating treatment with GEFISTERIS 250, patients undergo molecular testing to confirm the presence of these mutations, ensuring that the therapy is appropriately matched to their specific cancer biology.\nPrimary Uses and Indications of GEFISTERIS 250\nGEFISTERIS 250 is primarily indicated for the treatment of adult patients with metastatic non-small cell lung cancer whose tumors have specific EGFR mutations. The medication is approved for both first-line treatment in newly diagnosed patients and for those whose disease has progressed after platinum-based chemotherapy.\nFirst-Line Treatment: When EGFR mutations are detected in treatment-naïve patients, GEFISTERIS 250 offers an excellent first-line option, often providing superior progression-free survival compared to traditional chemotherapy regimens. Patients starting with targeted therapy typically experience better tolerability and quality of life during initial treatment phases.\nSecond-Line and Beyond: For patients whose cancer has progressed after chemotherapy, GEFISTERIS 250 provides an effective alternative treatment option, particularly when EGFR mutation testing was not performed initially or when the mutation status was unknown at the time of first treatment.\nThe medication is taken orally as a once-daily tablet, offering significant convenience compared to intravenous chemotherapy that requires hospital visits and lengthy infusion times. This oral administration allows patients to maintain greater independence and normalcy in their daily lives while receiving effective cancer treatment.\nKey Benefits of GEFISTERIS 250\n1. Targeted Cancer Fighting Action\nThe primary benefit of GEFISTERIS 250 lies in its precision targeting mechanism. Unlike conventional chemotherapy that attacks all rapidly dividing cells in the body, GEFISTERIS 250 specifically targets cancer cells bearing EGFR mutations. This selective action means that healthy cells are largely spared, resulting in a more favorable side effect profile and better preservation of normal bodily functions during treatment.\n2. Superior Efficacy in EGFR-Mutant NSCLC\nClinical trials have consistently demonstrated that GEFISTERIS 250 and other EGFR-TKIs provide superior progression-free survival compared to chemotherapy in patients with EGFR-mutant NSCLC. Response rates typically range from 60-80% in appropriate patient populations, with many patients experiencing significant tumor shrinkage and symptomatic improvement within weeks of starting treatment.\n3. Improved Quality of Life\nPatients taking GEFISTERIS 250 often report better quality of life compared to those receiving traditional chemotherapy. The medication's targeted nature results in fewer debilitating side effects such as severe nausea, hair loss, and profound fatigue. Many patients can continue working, traveling, and engaging in normal daily activities while on treatment.\n4. Convenient Oral Administration\nGEFISTERIS 250's once-daily oral dosing eliminates the need for frequent hospital visits for intravenous chemotherapy infusions. Patients take one tablet daily at home, providing tremendous convenience and reducing the burden of treatment. This ease of administration contributes significantly to treatment adherence and patient satisfaction.\n5. Rapid Symptom Relief\nMany patients experience rapid improvement in cancer-related symptoms such as cough, shortness of breath, chest pain, and fatigue within the first few weeks of GEFISTERIS 250 treatment. This quick symptomatic relief can dramatically improve quality of life even before significant tumor shrinkage is visible on imaging studies.\n6. Extended Survival Benefits\nLong-term data demonstrates that appropriate use of EGFR-TKIs like GEFISTERIS 250 contributes to extended overall survival in patients with EGFR-mutant lung cancer. When used as part of a comprehensive treatment strategy, including potential sequential therapies after progression, patients can achieve survival times that were unimaginable before the advent of targeted therapies.\n7. Manageable Side Effect Profile\nWhile GEFISTERIS 250 does cause side effects, they are generally more manageable than those associated with traditional chemotherapy. Most side effects can be effectively controlled with supportive medications, dose modifications, or temporary treatment interruptions, allowing patients to continue benefiting from therapy.\n8. Quality Manufacturing by Steris Healthcare\nGEFISTERIS 250 benefits from Steris Healthcare's commitment to pharmaceutical excellence. Each tablet undergoes rigorous quality testing to ensure consistent potency, purity, and bioavailability. This quality assurance means patients receive reliable, effective medication with every dose.\nSide Effects of GEFISTERIS 250 (Gefitinib 250mg)\nWhile GEFISTERIS 250 offers significant therapeutic benefits, patients should be aware of potential side effects. Understanding these effects enables early recognition and appropriate management.\nCommon Side Effects (Affecting 20% or More of Patients):\nSkin Reactions: The most characteristic side effect of GEFISTERIS 250 is an acne-like rash, typically appearing on the face, chest, and back within the first few weeks of treatment. This rash, while cosmetically concerning for some patients, actually correlates with better treatment response. The rash can be managed with topical antibiotics, moisturizers, and sun protection. In severe cases, temporary dose reduction may be necessary.\nDiarrhea: Approximately 50-60% of patients experience diarrhea of varying severity. Mild diarrhea can often be managed with dietary modifications and over-the-counter anti-diarrheal medications like loperamide. Patients should stay well-hydrated and contact their healthcare provider if diarrhea becomes severe or persistent, as dose adjustments may be needed.\nNail Changes: Some patients develop paronychia (nail bed inflammation) or other nail abnormalities. Proper nail care, avoiding trauma to the nail beds, and wearing protective gloves during housework can help minimize these effects.\nDry Skin: Many patients experience skin dryness and itching. Regular use of fragrance-free moisturizers, gentle cleansers, and avoidance of hot showers can help manage these symptoms.\nMouth Sores: Oral mucositis or stomatitis can develop in some patients. Good oral hygiene, avoiding spicy or acidic foods, and using alcohol-free mouthwashes can provide relief.\nLess Common but Serious Side Effects:\nInterstitial Lung Disease (ILD): While rare (1-2% of patients), ILD is the most serious potential side effect of GEFISTERIS 250. Symptoms include sudden onset or worsening of respiratory symptoms such as difficulty breathing, cough, or fever. This requires immediate medical attention and usually necessitates permanent discontinuation of the medication.\nLiver Function Abnormalities: Elevated liver enzymes can occur, requiring regular monitoring through blood tests. Most cases are asymptomatic and reversible with dose modification or temporary discontinuation.\nEye Problems: Dry eyes, corneal erosion, or other ocular issues may develop. Regular use of lubricating eye drops and ophthalmological evaluation when symptoms occur can prevent serious complications.\nGastrointestinal Perforation: Though rare, serious gastrointestinal complications including perforation can occur, particularly in patients with underlying GI conditions.\nManagement Strategies:\nMost side effects can be effectively managed through:\n\nProactive supportive care and prophylactic measures\nDose modifications (reduction to 250mg every other day in some cases)\nTemporary treatment interruptions allowing recovery\nSymptomatic treatment with appropriate medications\nPatient education about early recognition and reporting of symptoms\n\nPatients should maintain open communication with their healthcare team, reporting any new or worsening symptoms promptly. Regular monitoring through clinical visits and laboratory testing helps identify and address side effects before they become serious.\nDosage and Administration Guidelines\nThe standard dose of GEFISTERIS 250 is one 250mg tablet taken orally once daily, with or without food. The tablet should be swallowed whole with water and should not be crushed or chewed. If a dose is missed and it's been less than 12 hours since the scheduled time, patients should take the missed dose. If more than 12 hours have passed, skip the missed dose and resume the regular schedule—never double up on doses.\nTreatment continues until disease progression or unacceptable toxicity occurs. Some patients remain on GEFISTERIS 250 for months or even years if they continue to benefit without prohibitive side effects. Dose modifications may be necessary based on individual tolerance, typically reducing the frequency to every other day rather than lowering the individual dose.\nPrecautions and Important Considerations\nPatients taking GEFISTERIS 250 should be aware of several important precautions. The medication can cause harm to developing fetuses, so women of childbearing potential must use effective contraception during treatment and for at least two weeks after the last dose. Breastfeeding should be avoided during treatment and for two weeks after completion.\nGEFISTERIS 250 can interact with medications that affect stomach acid, including proton pump inhibitors and H2-receptor antagonists. If antacids are needed, they should be taken several hours apart from GEFISTERIS 250. The medication may also interact with certain other drugs metabolized by the liver, so patients should inform their healthcare provider about all medications, supplements, and herbal products they're taking.\nRegular monitoring is essential during GEFISTERIS 250 treatment, including periodic liver function tests, pulmonary symptom assessment, and clinical evaluation for skin and other toxicities. Patients should avoid prolonged sun exposure and use high-SPF sunscreen, as the medication can increase photosensitivity.\nConclusion\nGEFISTERIS 250 represents a transformative treatment option for patients with EGFR-mutant non-small cell lung cancer, offering targeted, effective therapy with a manageable side effect profile. Manufactured by Steris Healthcare with unwavering commitment to quality and patient outcomes, GEFISTERIS 250 delivers Gefitinib 250mg in a formulation designed for optimal bioavailability and consistent therapeutic effect.\nThe medication's precision targeting of cancer-driving mutations, combined with convenient oral administration and generally tolerable side effects, makes GEFISTERIS 250 an excellent choice for eligible patients. While side effects do occur and require monitoring and management, the potential benefits—including tumor response, symptom improvement, extended progression-free survival, and enhanced quality of life—often significantly outweigh the risks for appropriately selected patients.\nSuccess with GEFISTERIS 250 requires partnership between patients and their healthcare teams. Molecular testing to confirm EGFR mutation status before treatment, adherence to the prescribed regimen, proactive management of side effects, and regular monitoring all contribute to optimal outcomes. For many patients with EGFR-mutant lung cancer, GEFISTERIS 250 offers not just treatment, but genuine hope for extended, quality life.\nAs personalized medicine continues to evolve, medications like GEFISTERIS 250 exemplify the power of matching treatments to individual tumor characteristics. Steris Healthcare's commitment to delivering this advanced therapy with assured quality and accessibility ensures that more patients can benefit from the remarkable advances in targeted cancer treatment that Gefitinib 250mg represents.\n",
"price": 2760.0,
"discountamount": 828.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"food",
"Call",
"Uses",
"Rash",
"Note",
"NSCLC",
"Email",
"nausea",
"Dosage",
"spread",
"WhatsApp",
"diarrhea",
"Gefitinib",
"treatment",
"One tablet",
"GEFISTERIS",
"information",
"sterispharma",
"consultation",
"sterisonline",
"Side Effects",
"cancer cells",
"targeted therapy",
"Regular monitoring",
"healthcare provider",
"small cell lung cancer",
"healthcare professional",
"specific EGFR mutations",
"epidermal growth factor receptor",
"potential liver function alterations"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1530,
"imageuri": "https://productimages.withfloats.com/actual/667d25ffb56721898510e93e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/667d25ffb56721898510e93e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T10:56:06.808Z",
"updatedon": "2026-04-15T10:04:00.767Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//gefitinib-250mg/1530",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GEFISTERIS 250",
"category": "Oncology",
"tags": [
"gefitinib 250 mg uses",
"gefitinib 250 mg online purchase",
"gefitinib 250 mg tablets price in india",
"non-small cell lung cancer (NSCLC).",
"triggered by chemotherapy.",
"cancer biology.",
"Superior Efficacy in EGFR-Mutant NSCLC",
"gefitinib 250mg",
"gefitinib 250mg tablet",
"gefitinib 250mg tab",
"gefitinib 250 mg tablet uses in lung cancer",
"gefitinib tablets 250 mg dosage and benefits",
"gefitinib 250 mg price in india",
"gefitinib 250 mg EGFR inhibitor for NSCLC treatment india"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6635ed538e18ce14f428c0c1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tofacitinib 11 mg",
"description": "TACOTINIB ER 11 \nTACOTINIB ER 11 (Tofacitinib 11 mg Extended Release) – Comprehensive Product Overview\n\nTACOTINIB ER 11 contains Tofacitinib 11 mg in an extended-release formulation designed for convenient once-daily dosing. Tofacitinib belongs to a class of medicines known as Janus kinase (JAK) inhibitors. It works by modulating the immune system to reduce inflammation and control symptoms in certain autoimmune conditions. TACOTINIB ER 11 is prescribed under medical supervision to help patients manage chronic inflammatory diseases effectively and improve quality of life.\n\nWhat is Tofacitinib 11 mg?\n\nTofacitinib is an oral targeted synthetic disease-modifying anti-rheumatic drug (tsDMARD). Unlike traditional immunosuppressive therapies, it specifically blocks JAK enzymes involved in the inflammatory signaling pathway. By inhibiting these pathways, TACOTINIB ER 11 reduces the overactive immune response responsible for joint damage, swelling, pain, and other systemic symptoms.\n\nThe extended-release (ER) 11 mg formulation ensures a steady release of medication over 24 hours, maintaining consistent blood levels while improving convenience compared to twice-daily immediate-release options.\n\nIndications and Uses of TACOTINIB ER 11\n\nTACOTINIB ER 11 is commonly prescribed for the management of:\n\n1. Rheumatoid Arthritis (RA)\n\nA chronic autoimmune condition that causes inflammation in the joints, leading to pain, stiffness, swelling, and progressive joint damage. Tofacitinib helps reduce inflammation and slow structural damage.\n\n2. Psoriatic Arthritis (PsA)\n\nAn inflammatory arthritis associated with psoriasis. TACOTINIB ER 11 helps manage joint symptoms and improves physical function.\n\n3. Ulcerative Colitis (UC)\n\nA chronic inflammatory bowel disease affecting the colon. Tofacitinib may help reduce intestinal inflammation and induce remission in moderate to severe cases.\n\n4. Ankylosing Spondylitis (AS) (as advised by a physician)\n\nMay be used in selected patients where other treatments are not effective.\n\nTreatment should always be initiated and monitored by a qualified healthcare professional.\n\nHow TACOTINIB ER 11 Works\n\nTACOTINIB ER 11 targets intracellular signaling pathways involved in immune cell activation. By blocking Janus kinase enzymes (JAK1 and JAK3 primarily), it prevents the transmission of pro-inflammatory cytokine signals. This results in:\n\nReduced joint inflammation\n\nDecreased immune overactivity\n\nRelief from pain and stiffness\n\nSlowing of disease progression\n\nBecause it acts on immune pathways, regular medical monitoring is required during treatment.\n\nKey Benefits of TACOTINIB ER 11\n✔ Effective Inflammation Control\n\nReduces swelling, pain, and tenderness in affected joints or tissues.\n\n✔ Improved Physical Function\n\nEnhances mobility and daily activity performance in patients with rheumatoid or psoriatic arthritis.\n\n✔ Convenient Once-Daily Dosing\n\nExtended-release 11 mg formulation improves patient compliance.\n\n✔ Targeted Mechanism of Action\n\nSpecifically inhibits JAK pathways, offering a modern therapeutic approach.\n\n✔ Reduced Disease Progression\n\nHelps prevent long-term structural joint damage when used appropriately.\n\n✔ Oral Administration\n\nUnlike some biologic therapies, TACOTINIB ER 11 is taken orally, eliminating the need for injections.\n\nDosage and Administration\n\nThe usual recommended dose is one tablet (11 mg) once daily, or as prescribed by your physician.\n\nTablets should be swallowed whole with water.\n\nDo not crush, chew, or split the tablet.\n\nCan be taken with or without food.\n\nDosage adjustments may be required in patients with liver impairment, kidney problems, or when used alongside certain medications.\n\nPossible Side Effects of TACOTINIB ER 11\n\nLike all medications, TACOTINIB ER 11 may cause side effects. Not everyone experiences them, but it is important to be aware of potential risks.\n\nCommon Side Effects:\n\nUpper respiratory tract infections\n\nHeadache\n\nDiarrhea\n\nNausea\n\nIncreased cholesterol levels\n\nMild increase in liver enzymes\n\nSerious Side Effects:\n\nSerious infections (tuberculosis, bacterial, viral, or fungal infections)\n\nBlood clots (deep vein thrombosis or pulmonary embolism)\n\nCardiovascular events in high-risk individuals\n\nReduced white blood cell count\n\nIncreased risk of certain cancers (with long-term use)\n\nSeek immediate medical attention if you experience:\n\nPersistent fever\n\nShortness of breath\n\nChest pain\n\nSevere abdominal pain\n\nUnusual bruising or bleeding\n\nRegular blood tests are required to monitor liver function, cholesterol levels, and blood cell counts during treatment.\n\nPrecautions and Warnings\n\nBefore starting TACOTINIB ER 11, inform your doctor if you:\n\nHave a history of recurrent infections\n\nHave liver or kidney disease\n\nHave tuberculosis or hepatitis\n\nAre pregnant or planning pregnancy\n\nAre breastfeeding\n\nHave a history of blood clots or cardiovascular disease\n\nVaccinations should be updated before initiating therapy. Live vaccines are generally not recommended during treatment.\n\nDrug Interactions\n\nTACOTINIB ER 11 may interact with:\n\nStrong CYP3A4 inhibitors (e.g., certain antifungals)\n\nImmunosuppressive drugs\n\nBiologic DMARDs\n\nCertain antibiotics\n\nAlways inform your healthcare provider about all medications and supplements you are taking.\n\nStorage Instructions\n\nStore below 25°C in a dry place\n\nProtect from moisture and direct sunlight\n\nKeep out of reach of children\n\nWho Should Avoid TACOTINIB ER 11?\n\nThis medication may not be suitable for:\n\nPatients with active serious infections\n\nIndividuals with severe liver impairment\nPatients at high risk of blood clots without proper medical supervision\nA detailed medical evaluation is necessary before starting therapy.\n\nConclusion\nTACOTINIB ER 11 (Tofacitinib 11 mg Extended Release) is an advanced oral treatment option for managing moderate to severe autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. By targeting JAK pathways, it effectively reduces inflammation, improves mobility, and enhances overall quality of life.\n",
"price": 795.0,
"discountamount": 239.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"mg",
"class",
"headache",
"response",
"guidance",
"monitoring",
"medication",
"TACOTINIB ER",
"inflammation",
"Janus kinase",
"immune system",
"joint function",
"JAK) inhibitors",
"sustained relief",
"prescribed dosage",
"healthcare provider",
"psoriatic arthritis",
"Common side effects",
"rheumatoid arthritis",
"extended-release formulation",
"Tofacitinib Extended Release",
"gastrointestinal disturbances",
"upper respiratory tract infections"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1102,
"imageuri": "https://productimages.withfloats.com/actual/6635ed8ae837fe0918c055ff.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6635ed8ae837fe0918c055ff.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-05-04T08:09:55.768Z",
"updatedon": "2026-03-14T06:26:01.73Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tofacitinib-11-mg/1102",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TACOTINIB ER 11",
"category": "ORTHOLOGYRANG",
"tags": [
"tofacitinib 11 mg",
"tofacitinib 11 mg tablet",
"tofacitinib 11 mg price",
"tab tofacitinib 11 mg",
"tofacitinib 11 mg uses",
"Tofacitinib 11 mg extended release tablets",
"Tofacitinib 11 mg ER for psoriatic arthritis treatment",
"Tofacitinib 11 mg tablet uses and benefits",
"Tofacitinib 11 mg ER dosage guide",
"Tofacitinib 11 mg side effects and precautions",
"Tofacitinib 11 mg daily autoimmune treatment"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "662b9f97a4eb611de48dd113",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Nintedanib 150 mg",
"description": "\nIntroduction to Nintedanib 150 mg\n\nNintedanib 150 mg is a widely prescribed medicine used in the management of serious lung conditions that cause progressive scarring and breathing difficulties. It belongs to a class of medicines known as tyrosine kinase inhibitors, designed to slow down the progression of lung fibrosis and improve overall respiratory health. Doctors commonly recommend Nintedanib 150 mg for patients suffering from conditions such as idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases (ILDs), and systemic sclerosis-associated interstitial lung disease.\n\nPatients searching for an effective medicine to manage worsening lung fibrosis often choose Nintedanib 150 mg because of its clinically proven effectiveness in slowing disease progression. With growing awareness about pulmonary fibrosis treatment, this medicine has become an important therapeutic option in respiratory care.\n\nWhat is Nintedanib 150 mg?\nf(x)=e\n−kx\nA\nk\ny=Ae\n−kt\n≈6e\n−0.6t\ny\nt\n\nNintedanib 150 mg capsules are oral prescription medicines formulated to reduce the rate of decline in lung function. It works by blocking pathways responsible for abnormal tissue scarring in the lungs. The medicine helps prevent further fibrosis and supports patients in maintaining better breathing capacity over time.\n\nNintedanib is mainly prescribed for:\n\nIdiopathic Pulmonary Fibrosis (IPF)\nProgressive Fibrosing Interstitial Lung Disease (PF-ILD)\nSystemic Sclerosis-Associated ILD\nCertain chronic pulmonary disorders involving fibrosis\n\nThe medicine is generally taken twice daily or as directed by a healthcare professional.\n\nHow Does Nintedanib 150 mg Work?\n\nNintedanib 150 mg works by inhibiting multiple growth factor receptors involved in fibrosis formation. These receptors are responsible for the excessive production of fibrous tissue inside the lungs. By blocking these signals, the medicine slows the progression of lung scarring.\n\nThis mechanism helps in:\n\nSlowing lung function decline\nReducing fibrosis progression\nImproving breathing stability\nSupporting long-term respiratory health\n\nUnlike medicines that only relieve symptoms, Nintedanib focuses on controlling the progression of the disease itself.\n\nKey Benefits of Nintedanib 150 mg\n1. Slows Disease Progression\n\nOne of the major advantages of Nintedanib 150 mg is its ability to reduce the speed at which lung scarring worsens. This is especially important for patients with progressive pulmonary fibrosis.\n\n2. Helps Maintain Lung Function\n\nRegular use may help preserve lung capacity and improve the patient’s ability to perform daily activities with reduced breathlessness.\n\n3. Clinically Proven Therapy\n\nNintedanib has been extensively studied in clinical trials and is considered an effective treatment option for fibrotic lung diseases.\n\n4. Oral Capsule Form\n\nThe medicine is easy to administer in capsule form, making treatment more convenient for long-term use.\n\n5. Supports Quality of Life\n\nBy slowing disease progression, patients may experience better mobility, reduced respiratory complications, and improved overall quality of life.\n\nUses of Nintedanib 150 mg\nIdiopathic Pulmonary Fibrosis (IPF)\n\nIPF is a chronic lung disease that causes gradual scarring of lung tissue. Nintedanib helps slow the worsening of this condition.\n\nProgressive Fibrosing ILD\n\nPatients with fibrosing interstitial lung diseases may benefit from reduced progression and stabilized respiratory performance.\n\nSystemic Sclerosis-Associated ILD\n\nNintedanib is also prescribed for lung complications related to systemic sclerosis, an autoimmune disorder.\n\nChronic Lung Fibrosis Management\n\nDoctors may recommend Nintedanib 150 mg for other chronic pulmonary fibrosis conditions requiring anti-fibrotic treatment.\n\nDosage and Administration\n\nNintedanib 150 mg should always be taken exactly as prescribed by the healthcare provider.\n\nGeneral Dosage Guidelines\nUsually taken twice daily\nSwallow capsules whole with water\nPreferably taken with food\nMaintain a consistent dosing schedule\n\nPatients should not crush, chew, or open the capsules unless advised by a medical professional.\n\nImportant Precautions Before Using Nintedanib 150 mg\n\nBefore starting treatment, patients should inform their doctor about:\n\nLiver disorders\nHeart disease\nBleeding disorders\nRecent surgeries\nPregnancy or breastfeeding\nExisting medications or supplements\n\nRoutine monitoring may be required during treatment to assess liver function and overall health status.\n\nPossible Side Effects of Nintedanib 150 mg\n\nLike all medicines, Nintedanib 150 mg may cause side effects in some patients. Most side effects are manageable with proper medical supervision.\n\nCommon Side Effects\nDiarrhea\nNausea\nVomiting\nAbdominal pain\nLoss of appetite\nWeight loss\nSerious Side Effects\n\nSeek immediate medical attention if you notice:\n\nSevere liver problems\nChest pain\nUnusual bleeding\nSevere allergic reactions\nDifficulty breathing\n\nPatients should immediately consult their doctor if side effects become persistent or severe.\n\nWhy Patients Choose Nintedanib 150 mg\n\nPatients and healthcare professionals prefer Nintedanib 150 mg due to its targeted anti-fibrotic action and long-term clinical benefits. It addresses the root mechanism of fibrosis progression rather than only symptom management.\n\nKey reasons behind its growing demand include:\n\nProven effectiveness in IPF treatment\nImproved respiratory stability\nBetter long-term disease management\nTrusted anti-fibrotic therapy\nWidely recommended by specialists\nStorage Instructions\n\nTo maintain medicine effectiveness:\n\nStore below recommended temperature\nKeep away from direct sunlight\nProtect from moisture\nKeep out of reach of children\n\nAlways check the packaging for detailed storage guidelines.\n\nWho Should Avoid Nintedanib 150 mg?\n\nNintedanib may not be suitable for everyone. Patients with severe liver disease, high bleeding risk, or known hypersensitivity should avoid using this medicine unless specifically advised by a healthcare professional.\n\nPregnant women should avoid this medicine due to potential risks to the unborn baby.\n\nDrug Interactions\n\nNintedanib 150 mg may interact with certain medicines, including:\n\nBlood thinners\nAntibiotics\nAntifungal medicines\nLiver enzyme affecting drugs\nHerbal supplements\n\nAlways provide a complete medication history to the doctor before starting treatment.\n\nFrequently Asked Questions About Nintedanib 150 mg\nIs Nintedanib 150 mg used for lung fibrosis?\n\nYes, it is primarily used for treating pulmonary fibrosis and related lung disorders.\n\nCan Nintedanib cure pulmonary fibrosis?\n\nNo, it does not cure the disease but helps slow down disease progression.\n\nHow long should Nintedanib be taken?\n\nTreatment duration depends on the patient’s condition and doctor’s recommendation.\n\nCan I stop taking Nintedanib suddenly?\n\nDo not stop treatment without consulting your healthcare provider.\n\nIs Nintedanib a chemotherapy medicine?\n\nNo, it is an anti-fibrotic medicine used mainly for lung diseases.\n\nConclusion\n\nNintedanib 150 mg is an advanced anti-fibrotic medicine widely used for managing progressive lung diseases such as idiopathic pulmonary fibrosis and interstitial lung disorders. Its ability to slow fibrosis progression and preserve lung function makes it an important treatment option for patients seeking long-term respiratory support.",
"price": 1050.0,
"discountamount": 150.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"ILD",
"IPF",
"part",
"scarring",
"pathways",
"mechanism",
"NINTEDONE",
"Nintedanib",
"lung tissue",
"inflammation",
"lung function",
"150mg strength",
"targeted medication",
"disease progression",
"prescription medicine",
"various lung diseases",
"healthcare professionals",
"comprehensive treatment plan",
"idiopathic pulmonary fibrosis",
"other interstitial lung diseases"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 771,
"imageuri": "https://productimages.withfloats.com/actual/662b9f99326a2039bea2891b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/662b9f99326a2039bea2891b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-04-26T12:35:35.162Z",
"updatedon": "2026-05-20T06:37:55.747Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//nintedanib-150-mg/771",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "NINTEDONE 150",
"category": "NEPHROLOGYRANGE",
"tags": [
"Nintedanib 150 mg",
"nintedanib 150 mg uses",
"nintedanib 150 mg uses in hindi",
"nintedanib 150 mg price",
"nintedanib 150 mg price in india",
"nintedanib 150 mg side effects",
"tab nintedanib 150 mg price",
"tab nintedanib 150 mg uses in hindi",
"tab nintedanib 150 mg uses",
"nintedanib 150 mg tablet",
"side effects of nintedanib 150 mg",
"nintedanib 150 mg brands in india",
"nintedanib 150 mg cost"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6abe4471401ae1a1106d67d9",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Bisoprolol 1.25mg",
"description": "Bisoprolol 1.25mg is the smallest tablet strength of bisoprolol, a heart-selective beta-1 blocker. Doctors usually prescribe it to start treatment or to build up the dose gradually in people with high blood pressure, chronic stable heart failure, or fast heart rhythms. It suits older adults, people with mild heart failure, and anyone who reacts strongly to beta-blockers. The medicine slows the heartbeat and eases the force of each contraction, so the heart works less hard. BISOGARD 1.25 from Steris Healthcare Pvt. Ltd. comes in a strip pack of 15 tablets. It is a Schedule H medicine, so it must only be started, changed, or stopped on a doctor's advice.\n\nProduct Snapshot\n\nBrand: BISOGARD 1.25\nManufacturer/Marketer: Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company in India\nActive ingredient: Bisoprolol Fumarate 1.25mg\nForm: Tablet\nPack size: 15 tablets\nDrug class: Cardioselective beta-1 blocker\nLegal status: Schedule H (valid prescription required)\nAvailability: Through Steris Healthcare's authorized pharmacies and its B2B PCD franchise network across India\nWhat Is Bisoprolol 1.25mg?\n\nIf your doctor has just prescribed bisoprolol 1.25mg, you have been given the lowest dose on purpose. Bisoprolol is a cardioselective beta-1 blocker, meaning it acts mostly on receptors in the heart and has much less effect on the lungs and blood vessels. This is a major reason it is preferred over older, non-selective beta-blockers, especially for people who also have a mild breathing problem.\n\nThe 1.25mg tablet is not a “light” medicine for mild illness. It is a carefully chosen entry point. In heart failure, a weakened heart can struggle if its rate or pressure drops too quickly, so cardiologists follow a “start low, go slow” approach. Treatment begins at 1.25mg, the response is watched for one to two weeks, and the dose is raised step by step (commonly 2.5mg, 3.75mg, 5mg, 7.5mg, and up to 10mg) as the heart adapts. That is why BISOGARD 1.25 is often the first tablet a newly diagnosed heart failure patient takes.\n\nWhat Is Bisoprolol 1.25mg Used For?\n\nDoctors commonly prescribe this strength for:\n\nChronic heart failure (HFrEF): as the first step of dose titration in patients with a reduced ejection fraction, alongside ACE inhibitors/ARBs and diuretics\nHigh blood pressure: especially in older adults, people with low body weight, and those who are sensitive to blood-pressure-lowering drugs\nStable angina: to reduce the heart's oxygen demand and relieve chest discomfort\nAfter a heart attack: in selected patients, under a cardiologist's care\nHeart rate control in some arrhythmias: sometimes used off-label at a low dose to gently bring down a fast heart rate\n\nAt 1.25mg, bisoprolol is seldom meant as the long-term sole treatment for high blood pressure in an otherwise healthy adult. It is usually the first rung of a titration ladder, or a steady maintenance dose for patients who are unusually beta-blocker sensitive (older age, low body weight, or borderline low pressure or pulse).\n\nHow Does Bisoprolol Work?\n\nBisoprolol selectively blocks beta-1 adrenergic receptors, which are packed mainly into heart muscle. This leads to several effects:\n\nSlower heart rate: the heart has more time to fill and rest between beats\nGentler contractions: the heart muscle needs less oxygen and energy\nLess renin from the kidneys: this helps blood pressure fall gradually over time\nLower overall cardiac workload: a real advantage for a heart that already struggles to pump well, as in heart failure\nKey Benefits of BISOGARD 1.25\nA gentle starting dose, well suited to careful titration in frail or elderly patients\nHeart-focused action, with less effect on the lungs and peripheral blood vessels than non-selective beta-blockers\nOnce-daily dosing, which makes it easier to stay on treatment\nA guideline-recommended beta-blocker for HFrEF with well-established outcomes data [Reviewer note: insert specific outcome statistics/trial citation pending medical sign-off]\nMade by Steris Healthcare Pvt. Ltd. under WHO-GMP and ISO-certified standards\nDosage Guidance\nUsual starting dose (heart failure): 1.25mg once a day, preferably in the morning\nDose increases: typically every 1–2 weeks (2.5mg, 3.75mg, 5mg, 7.5mg, up to a maximum of 10mg daily), depending on how well you tolerate it and on your pulse and blood pressure\nHigh blood pressure (sensitive patients): 1.25mg to 5mg once daily, as set by your doctor\nHow to take it: at the same time every day, with or without food, swallowed whole with water\nIf you miss a dose: take it when you remember, unless the next dose is almost due. Never take a double dose.\nNever stop suddenly: abrupt withdrawal can cause a rebound rise in heart rate, blood pressure, or chest pain. The dose must be reduced gradually under medical supervision.\nIs It Better to Take Bisoprolol in the Morning or at Night?\n\nMost doctors advise a morning dose. Bisoprolol lowers pulse and blood pressure, and taking it early matches its action to your daytime activity. A night-time dose could add to the body's natural overnight dip in blood pressure and raise the chance of dizziness when getting up in the dark. Some people who feel tired during the day are told by their doctor to switch to the evening. Do not change your dosing time without your doctor's approval.\n\nSide Effects of Bisoprolol 1.25mg\n\nCommon side effects\n\nTiredness or fatigue\nDizziness or light-headedness, especially on standing quickly\nCold hands or feet\nSlow pulse (bradycardia)\nHeadache\nMild stomach upset (nausea, loose stools)\nDisturbed sleep\n\nSerious side effects (get medical help promptly)\n\nVery slow heartbeat or fainting\nIncreasing breathlessness or swollen legs/ankles, which may mean heart failure is worsening\nAllergic reaction: rash, swelling of the face or throat, trouble breathing\nCold, numb, or bluish fingers and toes\nWheezing or new breathing difficulty, particularly in people with asthma or COPD\nMood changes, low mood, or confusion\nWhat Are the Bad Side Effects of Bisoprolol?\n\nThe effects that need urgent attention are a dangerously slow pulse, fainting, signs of worsening heart failure (swelling, breathlessness), severe allergic reactions, and airway tightening in people with lung disease. These are uncommon at the 1.25mg dose, but anyone who notices them should seek medical help right away. [Reviewer note: specific incidence rates pending clinical/medical sign-off]\n\nSubstitutes & Comparable Beta-Blockers\nMolecule\tSelectivity\tTypical Use Case\nBisoprolol\tHighly cardioselective\tHeart failure titration, hypertension\nMetoprolol Succinate ER\tCardioselective\tHypertension, angina, heart failure\nAtenolol\tCardioselective (older agent)\tHypertension\nCarvedilol\tNon-selective with alpha-blocking action\tHeart failure (adds vasodilation)\nPropranolol\tNon-selective\tMigraine prevention, anxiety-related fast heartbeat, essential tremor\nPrecautions & Who Should Avoid Bisoprolol\nNot suitable for people with severe bradycardia, certain forms of heart block (unless a pacemaker is fitted), unstable or acutely decompensated heart failure, or severe uncontrolled asthma\nUse carefully in diabetes, because beta-blockers can hide the warning signs of low blood sugar\nTake care in peripheral vascular disease, as cold extremities or leg pain on walking may worsen\nNever stop it abruptly; always taper under a doctor's guidance\nTell your doctor about every medicine you use, especially other blood-pressure drugs, calcium channel blockers, and certain antiarrhythmics\nIn pregnancy and breastfeeding, use only if your doctor advises it after weighing benefits and risks\nIs Bisoprolol Safe for Kidneys?\n\nThe body clears bisoprolol through both the liver and the kidneys in roughly equal measure. It is generally considered safe for people with normal or mildly reduced kidney function. When kidney impairment is significant, drug levels in the blood can rise, so your doctor may lower the dose or monitor you more closely. Always tell your prescriber about any kidney disease before starting.\n\nIs Bisoprolol a High-Risk Medication?\n\nBisoprolol is not a narrow therapeutic index drug like tacrolimus or warfarin, where small dose differences matter greatly. Even so, it needs supervised use because it directly affects heart rate and blood pressure. The main dangers are stopping it suddenly, which can set off rebound cardiac events, and using it with certain existing rhythm disorders. Taken as prescribed and checked regularly, it has a long and reassuring safety record.\n\nDoes 1.25mg Bisoprolol Lower Blood Pressure?\n\nYes. Even the smallest dose measurably reduces heart rate and blood pressure by lightening the heart's workload and reducing renin-driven narrowing of blood vessels. At this strength the effect on blood pressure is fairly mild, which is exactly why it is a safe place to begin, especially for older adults or people starting heart failure treatment. The dose is then raised gradually to reach full benefit.\n\nFrequently Asked Questions\n\n1. What is 1.25 mg of bisoprolol used for?\nMainly as a low starting dose when building up treatment for chronic heart failure, and for high blood pressure in people who are very sensitive to beta-blockers, such as older adults.\n\n2. What are the bad side effects of bisoprolol?\nThe more serious ones are a very slow pulse, fainting, worsening heart failure signs (swelling, breathlessness), severe allergy, and breathing trouble in people with lung conditions.\n\n3. What are the common side effects of bisoprolol fumarate 1.25 mg tablets?\nTiredness, dizziness, cold hands and feet, mild headache, and a slightly slower pulse.\n\n4. Is it better to take bisoprolol in the morning or at night?\nMorning is usually preferred so its effect fits daytime activity, though your doctor may suggest evenings in some cases.\n\n5. What is the cost of bisoprolol?\nPrice depends on strength, pack size, and brand. Use the “Check Price” option above for current BISOGARD 1.25 pricing from Steris Healthcare.\n\n6. Does 1.25 mg bisoprolol lower blood pressure?\nYes, though only modestly at this dose. The dose is often stepped up over time.\n\n7. Is bisoprolol safe for kidneys?\nGenerally yes for normal or mildly reduced kidney function. People with significant kidney impairment need dose adjustment and monitoring.\n\n8. Is bisoprolol a high-risk medication?\nIt is not a narrow therapeutic index drug, but it must never be stopped suddenly and should be used under medical supervision because of its direct effect on the heart.\n\n9. Can I take bisoprolol 1.25mg for the rest of my life?\nMany people with chronic heart failure or hypertension do take bisoprolol long term, but the dose usually rises as tolerated. Your doctor should review it regularly.\n\n10. What happens if I miss a dose of bisoprolol?\nTake it when you remember, unless the next dose is nearly due. In that case skip the missed one. Never take two together.\n\n11. Can bisoprolol 1.25mg cause weight gain?\nIt is not commonly reported at this dose. Fluid retention linked to heart failure itself should be reported to your doctor.\n\n12. Is bisoprolol safe for diabetic patients?\nIt can be used, with care, because beta-blockers may hide warning signs of low blood sugar such as a racing heartbeat.\n\n13. Can I stop taking bisoprolol suddenly if I feel fine?\nNo. Stopping abruptly can cause a rebound rise in heart rate, blood pressure, or chest pain. Reduce the dose gradually under medical guidance.\n\n14. Does bisoprolol interact with other blood pressure medicines?\nYes. Combining it with other drugs that lower heart rate or pressure (such as calcium channel blockers) can cause a very low pulse or pressure. Tell your doctor about all your medicines.\n\n15. Is BISOGARD 1.25 available without a prescription?\nNo. Bisoprolol is a Schedule H medicine in India and needs a valid prescription.\n\n16. How long does it take for bisoprolol 1.25mg to start working?\nSome effect on heart rate appears within hours, but the full benefit for blood pressure or heart failure symptoms builds over several weeks of regular use.\n\n17. Can pregnant women take bisoprolol?\nOnly if clearly necessary and prescribed by a doctor, as it may affect the baby's heart rate and growth.",
"price": 39.0,
"discountamount": 12.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2501,
"imageuri": "https://productimages.withfloats.com/actual/6abe4474c205678e0b16a23a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6abe4474c205678e0b16a23a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-01T11:30:57.88Z",
"updatedon": "2026-10-01T11:30:57.88Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//bisoprolol-1-25mg/2501",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Bisogard 1.25",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a86e496cc4491de1ed77dfd",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Etoricoxib & Cyclobenzaprine Hydrochloride Tablets",
"description": "ERITOCOX BENZ 90/5 is a fixed-dose combination tablet pairing Etoricoxib 90 mg, a selective COX-2 anti-inflammatory, with Cyclobenzaprine Hydrochloride 5 mg, a centrally acting muscle relaxant. It is prescribed for short-term relief of acute musculoskeletal problems where pain, swelling, and muscle tightness occur together — think a sudden low-back strain, a stiff neck, or a flare-up of arthritis where the surrounding muscles clamp down defensively. Rather than treating the inflammation alone or the spasm alone, this tablet addresses both mechanisms in one dose, which can mean fewer pills and a more complete response for short, acute episodes. It is a prescription-only (Schedule H) medicine, produced under WHO-GMP and ISO-certified manufacturing standards by Steris Healthcare Pvt. Ltd. Typical side effects include drowsiness, dry mouth, and mild stomach upset; because the combination carries cardiovascular, gastrointestinal, and kidney considerations, it should only be used under a doctor's supervision. This page walks through what the tablet does, how it works, correct usage, safety information, and answers to the questions people most often ask.\n\nWhat Is ERITOCOX BENZ 90/5?\n\nPain from an acute back injury, a wrenched neck, or an arthritis episode almost never travels alone — it tends to bring a tense, guarded muscle along with it that makes every movement feel worse. ERITOCOX BENZ 90/5 was formulated with that pattern in mind, folding two separate mechanisms into a single tablet rather than requiring two prescriptions.\n\nActive Ingredient\tStrength\tRole\nEtoricoxib\t90 mg\tSelective COX-2 inhibitor for inflammatory pain\nCyclobenzaprine Hydrochloride\t5 mg\tCentrally acting skeletal muscle relaxant\n\nEach tablet is manufactured by Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company, so every batch meets verified potency and quality benchmarks.\n\nWhy This Combination Makes Sense\n\nMusculoskeletal pain is rarely a single-track problem. When tissue is injured or irritated, inflammation flares up locally — and nearby muscles frequently respond by tightening protectively. That protective tightening, the spasm, often becomes a pain generator of its own. Treat only the inflammation and the spasm can linger; treat only the spasm and the underlying inflammation keeps driving discomfort.\n\nERITOCOX BENZ 90/5 is built to intervene on both fronts at once:\n\nEtoricoxib addresses the chemical cascade responsible for pain and swelling at the injured site.\nCyclobenzaprine works through the central nervous system to calm the muscle guarding that so often rides alongside that pain.\nMechanism of Action: How ERITOCOX BENZ 90/5 Works\n\nEtoricoxib selectively inhibits the COX-2 enzyme — the enzyme the body ramps up at sites of tissue damage or irritation to manufacture prostaglandins, the chemical messengers behind pain, swelling, and localized heat. Because it targets COX-2 specifically rather than blocking both COX-1 and COX-2 the way older, non-selective NSAIDs do, etoricoxib is designed to control inflammatory pain while leaving more of the COX-1 activity that protects the stomach lining relatively undisturbed.\n\nCyclobenzaprine Hydrochloride takes a different route entirely — its primary site of action is the brainstem, not the muscle fiber itself. By dampening excessive motor signaling sent to skeletal muscle, it reduces spasm and stiffness without producing the broad muscle weakness that a directly-acting muscle agent might cause.\n\nPut together, the tablet delivers a two-pronged effect: peripheral anti-inflammatory action from etoricoxib, layered with central muscle relaxation from cyclobenzaprine.\n\n[Reviewer placeholder: insert verified pharmacokinetic data (onset, half-life, bioavailability) once confirmed by medical/regulatory team — do not publish unverified figures.]\n\nClinical Uses of ERITOCOX BENZ 90/5\n\nA physician may prescribe this combination for short-term management of acute conditions where pain, inflammation, and spasm show up together, including:\n\nCondition\tTypical Presentation\nAcute lower back pain\tPain with associated muscle guarding/spasm\nNeck strain / cervical spasm\tStiff, restricted neck movement\nSprains, strains, overuse injuries\tMusculoskeletal trauma with inflammatory pain\nOsteoarthritis flare-ups\tJoint pain accompanied by surrounding muscle tightness\nPostural or occupational muscle pain\tWork- or posture-related inflammation and tension\nMovement restriction linked to spasm\tReduced range of motion driven by muscular guarding\n\nSuitability for any of the above must be confirmed by a doctor based on your specific diagnosis and medical history.\n\nKey Benefits of ERITOCOX BENZ 90/5\nOne tablet, two mechanisms — anti-inflammatory pain relief and muscle-spasm relief combined, simplifying an otherwise two-drug regimen.\nSite-focused inflammation control — etoricoxib's COX-2 selectivity is intended to concentrate its effect where inflammation is actually active.\nA comparatively gentler GI footprint — COX-2-selective action is generally linked to lower gastrointestinal irritation risk than older non-selective NSAIDs, though vigilance is still warranted.\nLoosens spasm-related stiffness — cyclobenzaprine's central action helps release tight, guarded muscles restricting movement.\nAids functional recovery — easing both pain and spasm can make it more realistic to resume light activity, stretching, or physiotherapy once your doctor clears you.\nStreamlined short-course dosing — a once-daily schedule (as prescribed) cuts down pill burden versus taking an NSAID and a muscle relaxant separately.\nDosage & Administration\n\nThe following is general reference information — your doctor's specific prescription always takes precedence.\n\nTake ERITOCOX BENZ 90/5 exactly as prescribed, generally once a day, with or without food.\nSwallow the tablet whole with water; avoid crushing or chewing unless your doctor tells you otherwise.\nTreatment is typically short — anywhere from a few days to roughly two weeks — reflecting the acute, self-limiting nature of most pain-and-spasm episodes.\nIf a dose is missed, take it as soon as you remember, but skip it entirely if the next dose is nearly due. Never double up to make up for a missed dose.\nDo not extend the treatment period or adjust your dose independently, even if symptoms haven't fully resolved.\nSide Effects of ERITOCOX BENZ 90/5\nCommon Side Effects\nDrowsiness or sleepiness\nDizziness\nDry mouth\nHeadache\nStomach discomfort or indigestion\nNausea\nFatigue\nMild elevation in blood pressure in some individuals\nSerious Side Effects — Seek Medical Help Promptly\nSigns of gastrointestinal bleeding, such as black stools or vomiting blood\nA severe allergic reaction — swelling of the face or throat, breathing difficulty, or widespread rash\nChest pain, irregular heartbeat, or other symptoms suggestive of a cardiovascular event\nYellowing of the skin or eyes, which may point to liver involvement\nA noticeable drop in urine output, which may suggest kidney impairment\nSevere dizziness, confusion, or fainting\n\nIf any of these serious symptoms appear, stop the medicine and get medical attention immediately.\n\nPrecautions & Warnings\nShare your full medical history with your doctor before starting, including any heart, kidney, or liver conditions.\nUse cautiously — or avoid altogether — if you have a history of stomach ulcers or gastrointestinal bleeding.\nGenerally not advised for people with uncontrolled high blood pressure, existing heart disease, or a prior stroke, unless a doctor specifically clears its use.\nSteer clear of alcohol, since it can amplify cyclobenzaprine's sedative effect and add to gastrointestinal risk.\nCyclobenzaprine may cause drowsiness or dizziness — hold off on driving or operating machinery until you know how the tablet affects you.\nDon't combine ERITOCOX BENZ 90/5 with other NSAIDs, painkillers, or sedating medicines without checking with your doctor first.\nAvoid the medicine if you have known hypersensitivity to etoricoxib, cyclobenzaprine, or related compounds.\nNot generally recommended during pregnancy or breastfeeding unless a doctor specifically advises otherwise.\nAvoid combining with MAO inhibitors, or using shortly after stopping them.\nDrug Interactions to Flag With Your Doctor\n\nDisclose every prescription medicine, over-the-counter product, and supplement you take. Extra caution is needed around medicines affecting:\n\nBlood pressure regulation\nKidney function\nBlood clotting\nCentral nervous system activity (sedatives, other muscle relaxants)\nLiver metabolism\nOther anti-inflammatory or pain-relief medicines\nConclusion\n\nERITOCOX BENZ 90/5 brings Etoricoxib 90 mg and Cyclobenzaprine Hydrochloride 5 mg together to tackle a problem that rarely presents as a single issue — pain, inflammation, and muscle spasm that reinforce one another in acute musculoskeletal conditions. By acting on both the inflammatory and muscular sides of that cycle, it offers a more rounded short-term response than either ingredient could provide alone.\n\nGiven the genuine cardiovascular, gastrointestinal, kidney, and central-nervous-system considerations involved, ERITOCOX BENZ 90/5 is meant strictly for short, doctor-supervised courses — not casual or extended self-treatment. Always check with your doctor to confirm whether this combination is right for your condition, medical history, and current medications.\n\nPrescription only – consult your doctor.\n\nFrequently Asked Questions (Google & AI Mode / Voice Search Optimized)\n\n1. What is ERITOCOX BENZ 90/5 used for? It's typically prescribed for short-term relief of acute musculoskeletal issues — such as back pain, neck strain, or an arthritis flare-up — where pain, inflammation, and muscle spasm show up together.\n\n2. Is ERITOCOX BENZ 90/5 a muscle relaxant? It's a combination tablet: the muscle-relaxing effect comes from its Cyclobenzaprine Hydrochloride component, while Etoricoxib supplies the pain-relieving, anti-inflammatory action.\n\n3. Is Etoricoxib a strong painkiller? Etoricoxib is an effective selective COX-2 inhibitor typically used for moderate inflammation-related pain, such as arthritis or an acute musculoskeletal injury. Its appropriateness for your level of pain should be assessed by a doctor.\n\n4. Is Etoricoxib safe for the kidneys? As with other NSAIDs, etoricoxib can influence kidney function, particularly with extended use, higher doses, dehydration, or existing kidney disease. It should be used carefully and only under medical guidance if kidney health is a concern.\n\n5. Should ERITOCOX BENZ 90/5 be taken in the morning or at night? It's usually taken once a day at a time your doctor sets. Since cyclobenzaprine can cause drowsiness, many doctors lean toward an evening dose — but always stick to your specific prescription.\n\n6. What are the common side effects of ERITOCOX BENZ 90/5? Frequently reported effects include drowsiness, dizziness, dry mouth, headache, stomach discomfort, and mild fatigue. Most fade on their own, but persistent symptoms should be reported to your doctor.\n\n7. How fast does ERITOCOX BENZ 90/5 start working? Etoricoxib tends to absorb fairly quickly, and many people feel pain relief within roughly an hour, though onset can vary by individual and whether the tablet is taken with food.\n\n8. What should be avoided while on ERITOCOX BENZ 90/5? Skip alcohol, avoid taking other NSAIDs or painkillers without medical advice, and hold off on driving or operating machinery if you're feeling drowsy or dizzy.\n\n9. How many days can ERITOCOX BENZ 90/5 be taken? It's usually prescribed for a short stretch — a few days up to around two weeks — matching how acute conditions typically resolve. Anything longer needs your doctor's review.\n\n10. What are the benefits of ERITOCOX BENZ 90/5? It delivers combined relief from pain, inflammation, and muscle spasm in one tablet, which can make it easier to move normally and get back to daily activity sooner when used as directed.\n\n11. How safe is ERITOCOX BENZ 90/5? Taken exactly as prescribed and for the recommended duration, it's generally considered safe for most adults. It does carry cardiovascular, gastrointestinal, kidney, and liver-related risks that call for medical supervision, especially if you already have related conditions.\n\n12. Can ERITOCOX BENZ 90/5 be used for knee pain? Yes — its etoricoxib component is commonly used for joint pain tied to osteoarthritis or an acute injury, including the knee, by reducing the underlying inflammation. A doctor should confirm suitability first.\n\n13. Does ERITOCOX BENZ 90/5 cause drowsiness? Yes — drowsiness and dizziness are known effects linked to its cyclobenzaprine component. Avoid driving or tasks requiring full alertness until you know how it affects you.\n\n14. Can ERITOCOX BENZ 90/5 be bought without a prescription? No. This is a prescription-only medicine meant to be taken solely under a qualified doctor's supervision — it isn't meant for self-prescribing or extended use without medical oversight.\n\n15. Can ERITOCOX BENZ 90/5 be taken with food? It can generally be taken with or without food, though taking it with food may ease stomach discomfort for some people. Follow your doctor's specific instructions.\n\n16. Is ERITOCOX BENZ 90/5 habit-forming? Cyclobenzaprine isn't considered addictive with typical short-term use, but the tablet should still be taken only for the prescribed duration and not restarted on your own without medical advice.\n\n17. Who should avoid taking ERITOCOX BENZ 90/5? People with active stomach ulcers, significant heart, kidney, or liver disease, known hypersensitivity to NSAIDs, or those who are pregnant or breastfeeding should avoid it unless a doctor specifically clears its use.",
"price": 222.0,
"discountamount": 67.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2495,
"imageuri": "https://productimages.withfloats.com/actual/6a86e4990f089c4695c57658.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a86e4990f089c4695c57658.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-20T11:27:18.403Z",
"updatedon": "2026-08-20T11:27:18.403Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//etoricoxib-cyclobenzaprine-hydrochloride-tablets/2495",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ERITOCOX BENZ 90/5",
"category": "",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}